264P An open-label, uncontrolled study of magrolimab (ONO-7913) and nivolumab (ONO-4538) in combination with standard modified-FOLFIRINOX chemotherapy as first-line treatment in patients with metastatic pancreatic cancer
M. Ueno, H. Imaoka, Hiroyuki Isayama, Gou Murohisa et autres